NO20000010L - Velsmakende elementær medisinsk mat - Google Patents

Velsmakende elementær medisinsk mat

Info

Publication number
NO20000010L
NO20000010L NO20000010A NO20000010A NO20000010L NO 20000010 L NO20000010 L NO 20000010L NO 20000010 A NO20000010 A NO 20000010A NO 20000010 A NO20000010 A NO 20000010A NO 20000010 L NO20000010 L NO 20000010L
Authority
NO
Norway
Prior art keywords
formula
nutritional
source
calories
nutritionally complete
Prior art date
Application number
NO20000010A
Other languages
English (en)
Other versions
NO316732B1 (no
NO20000010D0 (no
Inventor
Phyllis J B Agosta
Marlene W Borschel
Patricia A Reynolds
Christopher T Cordle
Geralyn O Duska-Mceven
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of NO20000010D0 publication Critical patent/NO20000010D0/no
Publication of NO20000010L publication Critical patent/NO20000010L/no
Publication of NO316732B1 publication Critical patent/NO316732B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S426/00Food or edible material: processes, compositions, and products
    • Y10S426/801Pediatric

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Pediatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Jellies, Jams, And Syrups (AREA)
NO20000010A 1997-07-02 2000-01-03 Sammensetning egnet som elementaer medisinsk mat og hypoallergen, medisinsk mat NO316732B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/887,001 US5922766A (en) 1997-07-02 1997-07-02 Palatable elemental medical food
PCT/US1998/011986 WO1999001044A1 (en) 1997-07-02 1998-06-10 Palatable elemental medical food

Publications (3)

Publication Number Publication Date
NO20000010D0 NO20000010D0 (no) 2000-01-03
NO20000010L true NO20000010L (no) 2000-03-01
NO316732B1 NO316732B1 (no) 2004-04-19

Family

ID=25390249

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000010A NO316732B1 (no) 1997-07-02 2000-01-03 Sammensetning egnet som elementaer medisinsk mat og hypoallergen, medisinsk mat

Country Status (12)

Country Link
US (2) US5922766A (no)
EP (1) EP0994657B1 (no)
JP (1) JP4467650B2 (no)
AT (1) ATE258386T1 (no)
CA (1) CA2294086C (no)
DE (1) DE69821359T2 (no)
DK (1) DK0994657T3 (no)
ES (1) ES2215304T3 (no)
HK (1) HK1028713A1 (no)
NO (1) NO316732B1 (no)
PT (1) PT994657E (no)
WO (1) WO1999001044A1 (no)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6136858A (en) * 1994-01-10 2000-10-24 Abbott Laboratories Infant formula and methods of improving infant stool patterns
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5981590A (en) * 1997-03-17 1999-11-09 Probiotix, Inc. Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
JP3362350B2 (ja) * 1997-10-16 2003-01-07 味の素株式会社 反芻動物の肥育方法
US6288116B1 (en) * 1998-05-13 2001-09-11 Novartis Nutrition Ag Method of administration of a nutritional product to a person having renal failure
US6203820B1 (en) * 1998-05-28 2001-03-20 Brice E. Vickery Compositions and methods for enhancing protein anabolism and detoxification
FR2784601B1 (fr) * 1998-09-21 2000-11-17 Gerard Auberger Concentre hydrosoluble obtenu a partir d'une phase emulgatrice ou hydrosolubilisante et d'un complexe de matieres lipophiles liquides d'origine vegetale
PT951842E (pt) * 1999-01-20 2003-04-30 Nutricia Nv Formula de alimento adaptada para bebe
US6977245B2 (en) 1999-04-12 2005-12-20 The United States Of America As Represented By The Department Of Health And Human Services Oligodeoxynucleotide and its use to induce an immune response
US6214351B1 (en) * 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil
WO2001026665A1 (en) * 1999-10-15 2001-04-19 Bawa Rajan S Liquid nutritional supplement composition and method of preparation
EP1062873A1 (en) * 1999-12-13 2000-12-27 N.V. Nutricia Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate
ATE378348T1 (de) * 2000-01-14 2007-11-15 Us Health Oligodeoxynukleotide und ihre verwendung zur induktion einer immunreaktion
US7585847B2 (en) * 2000-02-03 2009-09-08 Coley Pharmaceutical Group, Inc. Immunostimulatory nucleic acids for the treatment of asthma and allergy
HUP0204439A3 (en) * 2000-02-04 2004-12-28 Nestle Sa A method for maintaining or improving the synthesis of mucins
IT1316998B1 (it) * 2000-03-02 2003-05-26 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori.
UA77660C2 (en) * 2000-10-03 2007-01-15 Compositions and methods for reducing plasma lipoprotein a level in human
ATE320831T1 (de) * 2000-10-06 2006-04-15 Dmg Italia Srl Immunotrophische preparation zur behandlung von tonsilläre hypertrophie
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
DE10057290B4 (de) * 2000-11-17 2004-01-08 Fresenius Kabi Deutschland Gmbh Enteral zu verabreichendes Supplement zur parenteralen Ernährung oder partiellen enteralen/oralen Ernährung bei kritisch Kranken, chronisch Kranken und Mangelernährten
US7244463B2 (en) * 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US20120237626A9 (en) * 2000-12-05 2012-09-20 Palu Afa Kehaati Profiles of lipid proteins and inhibiting HMG-CoA reductase
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US7048952B2 (en) * 2002-05-21 2006-05-23 Morinda, Inc. Formulation for inhibiting fungal and microbial growth comprising morinda citrifolia puree juice
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
DE20101225U1 (de) * 2001-01-24 2001-06-13 Sportmedizin Team Vertriebs Gm Präparat für hohe körperliche Beanspruchung
JP2004527501A (ja) * 2001-03-05 2004-09-09 ピー. アーネスト,スティーヴン 経腸処方
EP1372412A2 (en) * 2001-03-09 2004-01-02 Societe Des Produits Nestle S.A. Composition improving age-related physiological deficits and increasing longevity
US7018662B2 (en) * 2001-04-17 2006-03-28 Morinda, Inc. Palliative effects of morinda citrifolia oil and juice
FR2825003B1 (fr) 2001-05-28 2005-01-28 Taan Aboudiab Dispositif pour un aliment dietetique de substitution au lait et au soja
AUPR626201A0 (en) * 2001-07-10 2001-08-02 Bioscreen Pty Ltd A composition for use in prophylaxis and/or treatment
US7666674B2 (en) 2001-07-27 2010-02-23 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of sterically stabilized cationic liposomes to efficiently deliver CPG oligonucleotides in vivo
AU784852B2 (en) * 2001-08-10 2006-07-06 Mars, Incorporated Canine support diet
WO2003020884A2 (en) * 2001-08-14 2003-03-13 The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services Method for rapid generation of mature dendritic cells
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
US20030109582A1 (en) * 2001-12-10 2003-06-12 Zasloff Michael A. Methods and compositions for stimulating secretions from paneth cells
US8466116B2 (en) 2001-12-20 2013-06-18 The Unites States Of America As Represented By The Secretary Of The Department Of Health And Human Services Use of CpG oligodeoxynucleotides to induce epithelial cell growth
WO2003054161A2 (en) * 2001-12-20 2003-07-03 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services USE OF CpG OLIGODEOXYNUCLEOTIDES TO INDUCE ANGIOGENESIS
AU2002367129A1 (en) * 2001-12-25 2003-07-15 Ajinomoto Co., Inc. Organ fibrosis inhibitors
US8263091B2 (en) * 2002-09-18 2012-09-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method of treating and preventing infections in immunocompromised subjects with immunostimulatory CpG oligonucleotides
GB2396809A (en) * 2003-01-03 2004-07-07 Vitabiotics Ltd Composition for the treatment of HIV and AIDS
US7297677B2 (en) * 2003-02-14 2007-11-20 Mars Incorporated Method of improving the skin barrier function of a pet
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
WO2005110123A1 (en) * 2003-04-25 2005-11-24 Abbott Laboratories Stable nutritional powder containing ascorbyl palmitate
US20050106275A1 (en) * 2003-05-02 2005-05-19 Chen Su Morinda citrifolia-based formulation for inhibiting metastasis of carcinogenic cells
US7824706B2 (en) 2003-05-09 2010-11-02 Freedom Health, Llc Dietary supplement and method for the treatment of digestive tract ulcers in equines
US7988989B2 (en) 2003-05-09 2011-08-02 Freedom Health, Llc Nutritional product for enhancing growth and/or strengthening the immune system of equine foals
US20050058671A1 (en) * 2003-05-09 2005-03-17 Bedding Peter M.J. Dietary supplement and method for treating digestive system-related disorders
US7658964B2 (en) 2003-05-09 2010-02-09 Freedom Health, Llc Dietary supplement and method for increasing the colostrum immunoglobulin levels in equine mares
ES2282880T3 (es) * 2003-05-22 2007-10-16 N.V. Nutricia Metodo para tratar o prevenir heridas cronicas y composicion nutritiv a completa comprendiendo glicina y/o leucina para usar en este.
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
PT1658079E (pt) * 2003-08-19 2012-07-12 Pharmaton Sa Xarope multivitaminico para crianças ou jovens
BRPI0412634A (pt) * 2003-09-10 2006-09-26 Unilever Nv composição comestìvel
JP4147280B2 (ja) * 2003-12-16 2008-09-10 独立行政法人理化学研究所 グルタミン含有エネルギー付加型アミノ酸組成物又はアミノ酸溶液
JP2007517026A (ja) * 2003-12-24 2007-06-28 エヌ.ブイ.・ヌートリシア パントテン酸又はその誘導体を含む組成物、及び食欲を増進するためのその使用
US20070031534A1 (en) * 2004-02-27 2007-02-08 Hajime Tsujimoto Pet food for reducing food allergy reactions
US20050260291A1 (en) * 2004-03-10 2005-11-24 Palu Afa K Methods and compositions for reactivating acetylcholinesterase
WO2005110124A1 (en) * 2004-04-15 2005-11-24 Abbott Laboratories Composition and methods for nutritional management of patients with hepatic disease
CN103734746B (zh) 2004-07-19 2017-01-11 纽崔西亚公司 天冬氨酸用于调节血中葡萄糖水平的用途
US20060088611A1 (en) * 2004-09-01 2006-04-27 Paulus Wang Morinda citrifolia-based formulations and methods for weight management
US20060141076A1 (en) * 2004-11-01 2006-06-29 Palu Afa K Morinda citrifolia based compositions and methods for inhibiting xanthine oxidase
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US7982066B2 (en) 2005-12-09 2011-07-19 Novalife, Inc. High protein supplement
US20070237848A1 (en) * 2005-12-21 2007-10-11 Brad Rawson MORINDA CITRIFOLIA BASED COMPOSITIONS FOR TREATMENT OF ANTI-INFLAMMATORY DISEASES THROUGH INHIBITION OF COX-1, COX-2, INTERLEUKIN-1beta, INTERLEUKIN-6, TNF-alpha, HLE, AND iNOS
US20070202058A1 (en) * 2006-02-27 2007-08-30 Calwood Nutritionals, Inc. Compositions for treating gastric reflux
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
WO2008010472A1 (fr) * 2006-07-18 2008-01-24 Ajinomoto Co., Inc. Composition pour nutrition entérale totale
US8722120B2 (en) * 2006-08-02 2014-05-13 Mead Johnson Nutrition Company Amino acid-based nutritional formulations
ES2507553T3 (es) * 2006-08-02 2014-10-15 Johannes Gutenberg-Universität Mainz Fármaco contra intoxicaciones por LCT
CN101795579A (zh) * 2006-08-04 2010-08-04 Shs国际有限公司 无蛋白配方
US20080226758A1 (en) * 2006-11-28 2008-09-18 Shixin Deng Lipoxygenase and Cyclooxygenase Inhibition
US20080213415A1 (en) * 2007-02-08 2008-09-04 Palu Afa K Treatment of Glaucoma and Diabetic Retinopathy with Morinda Citrifolia Enhanced Formulations
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
TWI478709B (zh) * 2008-02-19 2015-04-01 Earnest Medicine Co Ltd A useful oral or enteral composition for the recovery of bodily functions
JP5527986B2 (ja) * 2008-02-19 2014-06-25 株式会社アーネストメディスン 医薬組成物
US7819382B2 (en) * 2008-05-09 2010-10-26 Gm Global Technology Operations, Inc. Temperature and pressure responsive seal
EP2143340A1 (en) * 2008-07-07 2010-01-13 Nestec S.A. A nutritional composition with free amino acids and structured lipids
JP2011121888A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121889A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011121887A (ja) * 2009-12-09 2011-06-23 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用アミノ酸組成物
JP2011144116A (ja) * 2010-01-12 2011-07-28 En Otsuka Pharmaceutical Co Ltd 炎症性腸疾患用添加剤
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
WO2014062683A1 (en) 2012-10-15 2014-04-24 University Of Florida Research Foundation, Inc. Materials and methods for prevention and treatment of diarrhea and inflammation in the gastrointestinal tract
PL2988617T3 (pl) 2013-03-27 2024-02-19 Nutritional Growth Solutions Ltd Suplement odżywczy do poprawy wzrostu
US11026913B2 (en) 2013-09-05 2021-06-08 Emory University Nutritional formulas comprising medium chain fatty acids or esters thereof and methods related thereto
US10124036B2 (en) 2015-06-12 2018-11-13 Cambrooke Therapeutics, Inc. Liquid nutritional formula for tyrosinemia patients
ES2914650T3 (es) * 2016-04-27 2022-06-15 Abergavenny Nv Sal de butirato de colina
FR3059522B1 (fr) * 2016-12-02 2019-01-25 Ajinomoto Co., Inc. Aliment et son utilisation pour la prophylaxie ou l'amelioration de la malnutrition
JP2021529735A (ja) * 2018-06-20 2021-11-04 アクセラ・ヘルス・インコーポレイテッドAxcella Health Inc. アミノ酸組成物の製造方法
JP7458620B2 (ja) 2019-06-21 2024-04-01 株式会社大塚製薬工場 栄養組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4414238A (en) * 1981-12-24 1983-11-08 Cutter Laboratories, Inc. Liquid elemental diet
US4670268A (en) * 1985-01-29 1987-06-02 Abbott Laboratories Enteral nutritional hypoallergenic formula
US5039704A (en) * 1985-09-12 1991-08-13 Brigham And Women's Hospital Method of treating catabolic dysfunction
US5411757A (en) * 1989-11-09 1995-05-02 Buist; Neil R. M. Palatable balanced amino acid-modified diet
KR0172193B1 (ko) * 1991-10-07 1999-02-01 오오쓰까 아끼히꼬 암 치료용 경장제제
US5234702A (en) * 1992-03-19 1993-08-10 Abbott Laboratories Antioxidant system for powdered nutritional products
WO1993020717A2 (en) * 1992-04-13 1993-10-28 Research Corporation Technologies, Inc. Reducing gastrointestinal irritation in infant nutrition
US5326569A (en) * 1992-12-23 1994-07-05 Abbott Laboratories Medical foods for the nutritional support of child/adult metabolic diseases
EP0675725B1 (en) * 1992-12-23 2002-01-30 Abbott Laboratories Medical foods for the nutritional support of infant/toddler metabolic diseases
US5340603A (en) * 1993-08-30 1994-08-23 Abbott Laboratories Nutritional product for human infants having chronic lung disease
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
US5492899A (en) * 1994-01-10 1996-02-20 Abbott Laboratories Infant nutritional formula with ribo-nucleotides
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition

Also Published As

Publication number Publication date
EP0994657A1 (en) 2000-04-26
JP4467650B2 (ja) 2010-05-26
US6245803B1 (en) 2001-06-12
CA2294086A1 (en) 1999-01-14
ATE258386T1 (de) 2004-02-15
DE69821359T2 (de) 2004-12-09
HK1028713A1 (en) 2001-03-02
CA2294086C (en) 2009-09-15
NO316732B1 (no) 2004-04-19
US5922766A (en) 1999-07-13
EP0994657B1 (en) 2004-01-28
DK0994657T3 (da) 2004-06-07
ES2215304T3 (es) 2004-10-01
NO20000010D0 (no) 2000-01-03
PT994657E (pt) 2004-06-30
WO1999001044A1 (en) 1999-01-14
DE69821359D1 (de) 2004-03-04
JP2002510317A (ja) 2002-04-02

Similar Documents

Publication Publication Date Title
NO20000010L (no) Velsmakende elementær medisinsk mat
ATE147592T1 (de) Vitamine und mineralien enthaltende nahrungszusätze
ATE257331T1 (de) Dietetische baby nahrungsmittel mit konjugierten linoleinsäuren
CY1109004T1 (el) Στοιχειακο εντερικο θρεπτικο προϊον που περιεχει υδρολυμενη πρωτεϊνη σογιας και μερικως υδρολυμενο καzεϊνικο
FR2721481B1 (fr) Nouvelles compositions diététiques à base de phospholipides et leur utilisation comme complément nutritionnel.
DK0784437T3 (da) Phospholipidholdig fedtblanding med LCP-fedtsyrer
DE60008127D1 (de) Diät mit hohem lipidgehalt
DE60218481D1 (de) Lipid mischungen und lebensmittel, enthaltend ölsäure und omega-6 fettsäuren, die die intramyozelluläre lipidkonzentration erhöhen
ATE248528T1 (de) Nahrungsmittel mit biotin und anderen b-vitaminen
NO951992D0 (no) Dietisk næringsmiddel med fettsyrer av middels lengde og anvendelse av dette
ATE84677T1 (de) Diaetoel.
DK1419699T3 (da) Levnedsmidler indeholdende fedt og salt
NZ330693A (en) Cooking aid in the shape of a lump with a granular surface
DE50202162D1 (de) Diätetisches Lebensmittel
FI964535A0 (fi) Ravinnevalmiste
DE60210245D1 (de) Diätetisches Milch- und Sojaersatzprodukt
ATE326973T1 (de) Neue verwendung von phospholiden pflanzlichen und tierischen ursprungs in nahrungstherapie
RU2002122530A (ru) Консервы на мясной основе для детей раннего возраста
TH57669B (th) "ผลิตภัณฑ์นมถั่วเหลืองที่มี epa ในปริมาณที่สูงและวิธีการผลิตเพื่อการนั้น"

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees